title: [ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment].
authors: Juan R
authors: JR
authors: de la Haba-Rodríguez
authors: María José
authors: MJ
authors: Ortiz-Morales
authors: María Auxiliadora
authors: MA
authors: Gómez-España
authors: Enrique
authors: E
authors: Aranda Aguilar
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D002607:Charcot-Marie-Tooth Disease / Q000150:complications / Q000235:genetics*; D003110:Colonic Neoplasms / Q000150:complications / Q000188:drug therapy; D054697:Cytostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004198:Disease Susceptibility; D005260:Female; D005838:Genotype; D006801:Humans; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics*; D009944:Organoplatinum Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D000077150:Oxaliplatin; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000209:etiology*; D020641:Polymorphism, Single Nucleotide
chemical_list: D000970:Antineoplastic Agents; D054697:Cytostatic Agents; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D017239:Paclitaxel; C421109:multidrug resistance-associated protein 1